logo
Plus   Neg
Share
Email

PepsiCo Q1 Results Top View; Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

Snack and beverage giant PepsiCo Inc. (PEP) on Tuesday reported a decline in net income for the first quarter, reflecting higher expenses despite an 7.7 percent growth in revenues.

However, both adjusted earnings per share and net revenues for the quarter beat analysts' estimates. The company also withdrew its earnings and revenue outlook for the full-year 2020.

"Our first quarter results reflect these efforts and the agility of our business which delivered high single-digit net revenue growth," said Chairman and CEO Ramon Laguarta.

For the first quarter, net income attributable to the company declined to $1.34 billion or $0.96 per share from $1.41 billion or $1.00 per share in the year-ago quarter.

The results for both quarters were impacted by restructuring charges and commodity mark-to-market impacts.

Core earnings for the quarter were $1.07 per share, compared to $.97 per share in the year-ago quarter. On average, 17 analysts polled by Thomson Reuters expected the company to earn $1.03 per share for the quarter.

Net revenue for the quarter grew 7.7 percent to $13.88 billion from $12.88 billion last year. Analysts expected revenues of $13.21 billion. Organic revenue growth for the quarter was 7.9 percent.

In the quarter, all its divisions - Frito-Lay North America, Quaker Foods North America, PepsiCo Beverages North America, Latin America, Europe, Africa, Middle East and South Asia as well as Asia Pacific, Australia and New Zealand and China Region - reported higher revenues.

Looking ahead to fiscal 2020, PepsiCo withdrew its core earnings per share and organic revenue growth guidance provided on February 13, 2020, given the uncertainties associated with the magnitude and duration of the COVID-19 pandemic on its business.

"Despite a strong first quarter, there is still a great deal of uncertainty that exists in relation to COVID-19, including how geographies, retail channels and consumer behaviors will evolve over time," Laguarta added.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT